| CASE REPORT |
|
| Year : 2022 | Volume
: 25
| Issue : 3 | Page : 373-375 |
|
|
Asymptomatic chronic-phase chronic myeloid leukemia BCR-ABL. (+) without splenomegaly: A case report
W Rajabto, YK Angkasa
Department of Internal Medicine, Division of Hematology.-Medical Oncology, Dr. Cipto Mangunkusumo General Hospital, Faculty of Medicine Universitas Indonesia, Jakarta, Indonesia
Correspondence Address:
Dr. Y K Angkasa
Jl. Pangeran Diponegoro No 71, RW 5, Kenari, Kec. Senen, Kota Jakarta Pusat, Daerah Khusus Ibukota, Jakarta - 10430
Indonesia
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/njcp.njcp_1401_21
|
|
|
Chronic Myeloid Leukemia (CML) is one of the myeloproliferative disorders characterized by Philadelphia chromosome presence. Contrary to Western countries, most CML patients in Indonesia present symptoms with splenomegaly as the most common finding. It is rare to find asymptomatic CML patients. We present a case of asymptomatic chronic-phase chronic myeloid leukemia BCR-ABL (+) without splenomegaly who achieved a hematologic and molecular response to imatinib.
|
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
